Add To Cart

Section 3
DSM-IV Classification

Question 3 | Test | Table of Contents

U.S. Department of Veterans Affairs 

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, press Ctrl “+” several times, then scroll.
Questions? Email: [email protected]

- Marcel O. Bonn-Miller, Ph.D. Cannabis & PTSD: Existing Evidence and Clinical Considerations. U.S. Department of Veterans Affairs, 2016, p25-28.

Peer-Reviewed Journal Article References:
Buckner, J. D., Morris, P. E., & Zvolensky, M. J. (2021). Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use. Experimental and Clinical Psychopharmacology, 29(3), 272–278.

Pearson, M. R. (2019). A meta-analytic investigation of the associations between cannabis use and cannabis-related negative consequences. Psychology of Addictive Behaviors, 33(3), 190–196.

Ridenour, T. A., Halliburton, A. E., & Bray, B. C. (2015). Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV? Psychology of Addictive Behaviors, 29(1), 211–217. 

Spradlin, A., Marcus, D. K., & Cuttler, C. (2020). The latent structure of cannabis misuse: A taxometric analysis. Psychological Assessment, 32(8), 803–808.

What are the symptoms of Cannabis Withdrawal in DSM-5? To select and enter your answer go to Test

Section 4
Table of Contents